NL-OMON53764
Recruiting
Not Applicable
Implementation of up-front ctDNA analysis into lung cancer care and development of liquid biopsy-based decision support models - the Lungmarker2 study - LM2 study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- lung cancer
- Sponsor
- Catharina-ziekenhuis
- Enrollment
- 800
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •first work\-up for suspected lung cancer
Exclusion Criteria
- •Presence of another malignant tumor, i.e. diagnosed with a tumor in the past 5
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
ongkankernet implementation ctDNA AnalysisNL-OMON50777Radboud Universitair Medisch Centrum250
Completed
Not Applicable
TLA Technology: a new DNA diagnostic test to sequence genes that cause the disease and detect new mutations: proof of concept study voor patients with Rendu-Osler-Weber disease.Rendu-Osler-Weber hereditary hemorrhagic telangiectasia10007510NL-OMON39779Sint Antonius Ziekenhuis45
Active, not recruiting
Phase 1
Single arm phase II study of ctDNA-guided encorafenib plus cetuximab retreatment in patients with BRAF V600E mutated mCRC. BRICKET studyCTIS2023-509088-26-00Gruppo Oncologico Del Nord Ovest16
Recruiting
Not Applicable
Catch the cancer; towards a cfDNA-based test for colorectal cancer screening<p>Lynch syndrome, colorectal cancer</p>NL-OMON29451Erasmus MC150
Completed
Not Applicable
Catch the cancer; towards a cfDNA-based test for colorectal cancer screeningcolorectal cancercolorectal carcinoma100180181001799010017991NL-OMON48193Erasmus MC, Universitair Medisch Centrum Rotterdam150